These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9120321)

  • 1. Monitoring the therapy of pulmonary tuberculosis by nested polymerase chain reaction assay.
    Yuen KY; Chan KS; Chan CM; Ho PL; Ng MH
    J Infect; 1997 Jan; 34(1):29-33. PubMed ID: 9120321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis.
    Kennedy N; Gillespie SH; Saruni AO; Kisyombe G; McNerney R; Ngowi FI; Wilson S
    J Infect Dis; 1994 Sep; 170(3):713-6. PubMed ID: 7661906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polymerase chain reaction technique in monitoring treatment of bacillary pulmonary tuberculosis].
    An S; Fan Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):392-4. PubMed ID: 11326874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can serial qualitative polymerase chain reaction monitoring predict outcome of pulmonary tuberculosis treatment?
    Chierakul N; Chaiprasert A; Tingtoy N; Arjratanakul W; Pattanakitsakul SN
    Respirology; 2001 Dec; 6(4):305-9. PubMed ID: 11844121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
    Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
    Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of smear-negative Mycobacterium tuberculosis by PCR and sequencing for rifampin resistance with DNA extracted directly from slides.
    Patnaik M; Liegmann K; Peter JB
    J Clin Microbiol; 2001 Jan; 39(1):51-2. PubMed ID: 11136747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of the Amplicor PCR assay for initial diagnosis and assessment of treatment response for pulmonary tuberculosis.
    Iinuma Y; Ichiyama S; Yamori S; Oohama J; Takagi N; Hasegawa Y; Shimokata K; Nakashima N
    Microbiol Immunol; 1998; 42(4):281-7. PubMed ID: 9623915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of tuberculosis patients undergoing standard anti-tuberculosis chemotherapy by using a polymerase chain reaction.
    Levée G; Glaziou P; Gicquel B; Chanteau S
    Res Microbiol; 1994 Jan; 145(1):5-8. PubMed ID: 8090986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis.
    van der Kuyp F; Mahan CS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1663-7. PubMed ID: 23131266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral-blood-based PCR assay to identify patients with active pulmonary tuberculosis.
    Condos R; McClune A; Rom WN; Schluger NW
    Lancet; 1996 Apr; 347(9008):1082-5. PubMed ID: 8602060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Day zero quantitative mRNA analysis as a prognostic marker in pulmonary tuberculosis category II patients on treatment.
    Singh UB; Rana T; Kaushik A; Porwal C; Makkar N
    Clin Microbiol Infect; 2012 Nov; 18(11):E473-81. PubMed ID: 23005345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
    Su WJ; Feng JY; Chiu YC; Huang SF; Lee YC
    Eur Respir J; 2011 Feb; 37(2):376-83. PubMed ID: 20516049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
    Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
    J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of fiberoptic bronchoscopy in culture-positive pulmonary tuberculosis patients whose pre-bronchoscopic sputum specimens were negative both for smear and PCR analyses.
    Tamura A; Shimada M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Ohshima N; Masuda K; Matsui H; Nagai H; Nagayama N; Toyota E; Akagawa S; Hebisawa A
    Intern Med; 2010; 49(2):95-102. PubMed ID: 20075571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of quantitative polymerase chain reaction, acid fast bacilli smear, and culture results in patients receiving therapy for pulmonary tuberculosis.
    Afghani B; Lieberman JM; Duke MB; Stutman HR
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):73-9. PubMed ID: 9368082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-existence of Mycobacterium tuberculosis and Mycobacterium intracellulare in one sputum sample.
    Takeda M; Ito W; Kobayashi N; Konno K; Takahashi T; Tatsuko R; Tomita N; Tanigai T; Chiba T; Yamaguchi K; Sato K; Ueki S; Kayaba H; Chihara J
    Intern Med; 2008; 47(11):1057-60. PubMed ID: 18520121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis.
    Tueller C; Chhajed PN; Buitrago-Tellez C; Frei R; Frey M; Tamm M
    Eur Respir J; 2005 Nov; 26(5):767-72. PubMed ID: 16264035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J; Lee BJ; Yoon HI; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.
    Chien JY; Chen YT; Shu CC; Lee JJ; Wang JY; Yu CJ; Yang PC
    Chest; 2013 Jun; 143(6):1725-1732. PubMed ID: 23288018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.